Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and ...
Sarah Sammons, MD, highlights the need for further investigation into trastuzumab deruxtecan in breast cancer treatment. Sarah Sammons, MD, medical oncologist, clinical investigator in the Breast ...
Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China ...
The other issue is KEYNOTE-189, our combination of KEYTRUDA and ... therapy (two candidates to date - ifinatamab deruxtecan (I-DXd) and patritumab deruxtecan - have delivered promising data ...
The use of "anno domini" and "before Christ" to mark time began in the early days of Christianity, and they're still used to track calendar years today. When reading historical texts or delving ...
The single-agent lapatinib has a limited role in managing BM, while its combination with capecitabine appears to deliver better results, particularly in patients who are not refractory to whole ...
Enhertu is a combination of a chemotherapy drug and ... Chemotherapy (with the ingredient deruxtecan-nxki): This part of the drug hinders and helps destroy cancer cells. Chemotherapy is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback